Bayer Ag Pk Stock Total Debt
| BAYRYDelisted Stock | USD 16.86 0.86 5.37% |
Bayer AG PK fundamentals help investors to digest information that contributes to Bayer AG's financial success or failures. It also enables traders to predict the movement of Bayer Pink Sheet. The fundamental analysis module provides a way to measure Bayer AG's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bayer AG pink sheet.
Bayer |
Bayer AG PK Company Total Debt Analysis
Bayer AG's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bayer AG Total Debt | 35.55 B |
Most of Bayer AG's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bayer AG PK is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Bayer AG PK has a Total Debt of 35.55 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is significantly lower than that of the firm.
Bayer Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bayer AG's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bayer AG could also be used in its relative valuation, which is a method of valuing Bayer AG by comparing valuation metrics of similar companies.Bayer AG is currently under evaluation in total debt category among its peers.
Bayer Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0576 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 87.41 B | ||||
| Shares Outstanding | 3.93 B | ||||
| Shares Owned By Institutions | 0.10 % | ||||
| Price To Earning | 12.46 X | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 1.02 X | ||||
| Revenue | 44.08 B | ||||
| Gross Profit | 27.04 B | ||||
| EBITDA | 6.45 B | ||||
| Net Income | 1000 M | ||||
| Cash And Equivalents | 9.07 B | ||||
| Cash Per Share | 2.31 X | ||||
| Total Debt | 35.55 B | ||||
| Debt To Equity | 1.08 % | ||||
| Current Ratio | 1.16 X | ||||
| Book Value Per Share | 10.50 X | ||||
| Cash Flow From Operations | 5.09 B | ||||
| Earnings Per Share | 1.28 X | ||||
| Price To Earnings To Growth | 1.31 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 102.3 K | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 64.01 B | ||||
| Total Asset | 120.24 B | ||||
| Working Capital | 8.49 B | ||||
| Current Asset | 25.17 B | ||||
| Current Liabilities | 16.68 B | ||||
| Z Score | 0.6 | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 4.08 % | ||||
| Net Asset | 120.24 B | ||||
| Last Dividend Paid | 2.0 |
About Bayer AG Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bayer AG PK's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bayer AG using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bayer AG PK based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Bayer Pink Sheet
If you are still planning to invest in Bayer AG PK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bayer AG's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |